Stanley-Laman Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
Stanley-Laman Group's RGEN Position: Q4 2021 in Review
Stanley-Laman Group sold out of Repligen (RGEN) in Q4 2021, closing a stake of 41,069 shares — an estimated $11.9M sold.
Stanley-Laman Group first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $11.9M in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.
- Stanley-Laman Group reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
- Stanley-Laman Group sold 41,069 Repligen shares in Q4 2021, an estimated $11.9M.
- Stanley-Laman Group first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
- Stanley-Laman Group's Repligen position peaked at $11.9M in Q3 2021.
- 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.
Based on Stanley-Laman Group's 13F filing for Q4 2021, filed 25 Jan 2022.